Kielbowski K, Krol M, Bakinowska E, Pawlik A
Membranes (Basel). 2024; 14(11).
PMID: 39590609
PMC: 11596214.
DOI: 10.3390/membranes14110223.
Parker J, Deme J, Lichtinger S, Kuteyi G, Biggin P, Lea S
Nat Commun. 2024; 15(1):8755.
PMID: 39384780
PMC: 11464717.
DOI: 10.1038/s41467-024-53096-6.
Newstead S, Parker J, Deme J, Lichtinger S, Kuteyi G, Biggin P
Res Sq. 2024; .
PMID: 38903084
PMC: 11188089.
DOI: 10.21203/rs.3.rs-4435259/v1.
Luo Y, Gao J, Jiang X, Zhu L, Zhou Q, Murray M
Pharmaceutics. 2023; 15(10).
PMID: 37896276
PMC: 10609898.
DOI: 10.3390/pharmaceutics15102517.
Schlessinger A, Zatorski N, Hutchinson K, Colas C
Trends Biochem Sci. 2023; 48(9):801-814.
PMID: 37355450
PMC: 10525040.
DOI: 10.1016/j.tibs.2023.05.011.
Equine Drug Transporters: A Mini-Review and Veterinary Perspective.
Rosa B
Pharmaceutics. 2020; 12(11).
PMID: 33171593
PMC: 7695171.
DOI: 10.3390/pharmaceutics12111064.
Toward a Systematic Structural and Functional Annotation of Solute Carriers Transporters-Example of the SLC6 and SLC7 Families.
Colas C
Front Pharmacol. 2020; 11:1229.
PMID: 32973497
PMC: 7466448.
DOI: 10.3389/fphar.2020.01229.
Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.
Colas C, Masuda M, Sugio K, Miyauchi S, Hu Y, Smith D
Mol Pharm. 2017; 14(12):4685-4693.
PMID: 29111754
PMC: 5826771.
DOI: 10.1021/acs.molpharmaceut.7b00775.
Functional implications and ubiquitin-dependent degradation of the peptide transporter Ptr2 in Saccharomyces cerevisiae.
Kawai K, Moriya A, Uemura S, Abe F
Eukaryot Cell. 2014; 13(11):1380-92.
PMID: 25172766
PMC: 4248705.
DOI: 10.1128/EC.00094-14.
The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogs.
Tsume Y, Borras Bermejo B, Amidon G
Pharmaceuticals (Basel). 2014; 7(2):169-91.
PMID: 24473270
PMC: 3942691.
DOI: 10.3390/ph7020169.
The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.
Tsume Y, Incecayir T, Song X, Hilfinger J, Amidon G
Eur J Pharm Biopharm. 2013; 86(3):514-23.
PMID: 24361461
PMC: 4243704.
DOI: 10.1016/j.ejpb.2013.12.009.
Structural basis for dynamic mechanism of proton-coupled symport by the peptide transporter POT.
Doki S, Kato H, Solcan N, Iwaki M, Koyama M, Hattori M
Proc Natl Acad Sci U S A. 2013; 110(28):11343-8.
PMID: 23798427
PMC: 3710879.
DOI: 10.1073/pnas.1301079110.
Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.
Newstead S, Drew D, Cameron A, Postis V, Xia X, Fowler P
EMBO J. 2010; 30(2):417-26.
PMID: 21131908
PMC: 3025455.
DOI: 10.1038/emboj.2010.309.
Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transporters.
Tsume Y, Vig B, Sun J, Landowski C, Hilfinger J, Ramachandran C
Molecules. 2008; 13(7):1441-54.
PMID: 18719516
PMC: 6244841.
DOI: 10.3390/molecules13071441.
Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.
Tsume Y, Hilfinger J, Amidon G
Mol Pharm. 2008; 5(5):717-27.
PMID: 18652477
PMC: 2659690.
DOI: 10.1021/mp800008c.
Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin.
Chanteux H, Van Bambeke F, Mingeot-Leclercq M, Tulkens P
Antimicrob Agents Chemother. 2005; 49(4):1279-88.
PMID: 15793098
PMC: 1068589.
DOI: 10.1128/AAC.49.4.1279-1288.2005.
Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson C, Mendoza M, Kennedy D, Raldua D, Thwaites D
Br J Pharmacol. 2003; 138(4):564-73.
PMID: 12598410
PMC: 1573691.
DOI: 10.1038/sj.bjp.0705049.
PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers.
Wenzel U, Kuntz S, Diestel S, Daniel H
Antimicrob Agents Chemother. 2002; 46(5):1375-80.
PMID: 11959571
PMC: 127140.
DOI: 10.1128/AAC.46.5.1375-1380.2002.
PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.
Buyse M, Berlioz F, Guilmeau S, Tsocas A, Voisin T, Peranzi G
J Clin Invest. 2001; 108(10):1483-94.
PMID: 11714740
PMC: 209419.
DOI: 10.1172/JCI13219.
Peptide transporter in the rat small intestine: ultrastructural localization and the effect of starvation and administration of amino acids.
Ogihara H, Suzuki T, Nagamachi Y, Inui K, Takata K
Histochem J. 1999; 31(3):169-74.
PMID: 10421416
DOI: 10.1023/a:1003515413550.